🔥🐔 BizChicken 🐔🔥

Companies Similar to Anebulo Pharmaceuticals, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Berubicin

CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company focused on developing anti-cancer drugs for brain and central nervous system tumors. Their lead drug candidate, Berubicin, targets glioblastoma multiforme through clinical trials and partnerships with notable institutions.

Tags: Anti-cancer drugs, Berubicin, Brain Tumors, CNS Tumors, Clinical Trials, Pharmaceuticals

Symbol: CNSP

Recent Price: $0.11

Industry: Biotechnology

CEO: Mr. John Michael Climaco Esq., J.D.

Sector: Healthcare

Employees: 3

Address: 2100 West Loop South, Houston, TX 77027

Phone: 800 946 9185

Last updated: 2024-12-31

ABVC BioPharma, Inc.

ABVC BioPharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

ABV-1501, ABV-1504, ABV-1505, ABV-1703, ABV-1702, ABV-1601, ABV-1701 Vitargus

ABVC Bio Pharma, Inc., based in Fremont, California, is a clinical stage biopharmaceutical company developing drugs and medical devices to address unmet medical needs in the United States. The company is involved in developing therapies for conditions such as cancer, major depressive disorders, and attention deficit hyperactivity disorder.

Tags: biopharmaceutical, clinical trials, drug development, medical devices, mental health, oncology

Symbol: ABVC

Recent Price: $0.59

Industry: Biotechnology

CEO: Dr. Uttam Yashwant Patil Ph.D.

Sector: Healthcare

Employees: 16

Address: 44370 Old Warm Springs Boulevard, Fremont, CA 94538

Phone: 510 668 0881

Last updated: 2024-12-31

AnaptysBio, Inc.

AnaptysBio, Inc. logo
Market Cap: Medium
Employees: Low

Imsidolimab, Rosnilimab, ANB032

Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.

Tags: antibody development, biotechnology, immuno-oncology, inflammation, therapeutics

Symbol: ANAB

Recent Price: $13.22

Industry: Biotechnology

CEO: Mr. Daniel R. Faga

Sector: Healthcare

Employees: 117

Address: 10770 Wateridge Circle, San Diego, CA 92121-5801

Phone: 858 362 6295

Last updated: 2024-12-31

AEON Biopharma, Inc.

AEON Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

ABP-450

AEON Biopharma, Inc. is a biopharmaceutical company focused on developing botulinum toxins for treating debilitating medical conditions. The company also develops ABP-450 for migraines, cervical dystonia, and gastroparesis.

Tags: ABP-450, biopharmaceutical, botulinum toxins, cervical dystonia, gastroparesis, medical conditions, migraines

Symbol: AEON

Recent Price: $0.56

Industry: Biotechnology

CEO: Mr. Marc Forth

Sector: Healthcare

Employees: 5

Address: 4040 Macarthur Boulevard, Newport Beach, CA 92614

Phone: 949-354-6499

Last updated: 2024-12-31

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Medium

Branded and generic prescription pharmaceuticals

ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals, focusing on controlled substances, oncology products, hormones, steroids, injectables, and other formulations in the United States and Canada.

Tags: biopharmaceutical, controlled substances, hormones, injectables, oncology, prescription drugs, steroids

Symbol: ANIP

Recent Price: $54.87

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Nikhil Lalwani

Sector: Healthcare

Employees: 642

Address: 210 Main Street West, Baudette, MN 56623

Phone: 218 634 3500

Last updated: 2024-12-31

Alto Neuroscience, Inc.

Alto Neuroscience, Inc. logo
Market Cap: Low
Employees: Low

ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.

Tags: AI-enabled biomarker, MDD, biopharmaceutical, cognitive impairment, drug development, psychiatry, schizophrenia

Symbol: ANRO

Recent Price: $4.20

Industry: Biotechnology

CEO: Dr. Amit Etkin M.D., Ph.D.

Sector: Healthcare

Employees: 78

Address: 369 South San Antonio Road, Los Altos, CA 94022

Phone: (650) 200-0412

Last updated: 2024-12-31

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Lowest

ACU193

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapies for Alzheimer's disease, with a key drug candidate ACU193 targeting amyloid-beta oligomers.

Tags: ACU193, Alzheimer's disease, biopharmaceutical, clinical-stage, immunotherapy

Symbol: ABOS

Recent Price: $1.75

Industry: Biotechnology

CEO: Mr. Daniel J. O'Connell M.B.A.

Sector: Healthcare

Employees: 51

Address: 427 Park Street, Charlottesville, VA 22902

Phone: 434 297 1000

Last updated: 2024-12-31

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANEB-001

Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing and commercializing treatments for acute cannabinoid intoxication and substance addiction, including their lead product candidate ANEB-001.

Tags: ANEB-001, biotechnology, cannabinoid intoxication, clinical-stage, substance addiction

Symbol: ANEB

Recent Price: $1.64

Industry: Biotechnology

CEO: Mr. Richard Anthony Cunningham

Sector: Healthcare

Employees: 2

Address: 1415 Ranch Road 620 South, Lakeway, TX 78734

Phone: 512 598 0931

Last updated: 2024-12-31

Annexon, Inc.

Annexon, Inc. logo
Market Cap: Medium
Employees: Low

ANX005

Annexon, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. It develops several investigational monoclonal antibodies targeting distinct disease processes.

Tags: autoimmune, biopharmaceutical, clinical trials, neurodegeneration, therapeutics

Symbol: ANNX

Recent Price: $5.13

Industry: Biotechnology

CEO: Mr. Douglas Love Esq., J.D.

Sector: Healthcare

Employees: 71

Address: 1400 Sierra Point Parkway, Brisbane, CA 94005

Phone: 650 822 5500

Last updated: 2024-12-31

Artelo Biosciences, Inc.

Artelo Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

ART27.13, ART12.11, ART26.12

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing treatments that modulate the endocannabinoid system, with a pipeline including treatments for cancer-related anorexia, inflammatory bowel disease, PTSD, prostate and breast cancer.

Tags: PTSD, biopharmaceutical, cancer treatment, clinical trial, endocannabinoid system, research collaboration, synthetic cannabidiol

Symbol: ARTL

Recent Price: $1.05

Industry: Biotechnology

CEO: Mr. Gregory D. Gorgas M.B.A.

Sector: Healthcare

Employees: 5

Address: 505 Lomas Santa Fe, Solana Beach, CA 92075

Phone: 858 925 7049

Last updated: 2024-12-31

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logo
Market Cap: Medium
Employees: Lowest

ANAVEX 2-73

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.

Tags: Alzheimer's, CNS diseases, Parkinson's, Rett syndrome, biopharmaceutical, clinical trials, neurodegenerative diseases

Symbol: AVXL

Recent Price: $11.04

Industry: Biotechnology

CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.

Sector: Healthcare

Employees: 40

Address: 51 West 52nd Street, New York, NY 10019

Phone: 844 689 3939

Last updated: 2024-12-31

Clever Leaves Holdings Inc.

Clever Leaves Holdings Inc. logo
Market Cap: Lowest
Employees: Low

cannabinoid and non-cannabinoid products

Clever Leaves Holdings Inc. is a cannabis company that operates in Cannabinoid and Non-Cannabinoid segments, focusing on international distribution of cannabinoid products and selling natural remedies and supplements in the United States.

Tags: Cannabinoid, Cannabis, Non-Cannabinoid, Nutraceuticals, Wellness

Symbol: CLVR

Recent Price: $0.03

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Andres Fajardo

Sector: Healthcare

Employees: 296

Address: 6501 Congress Avenue, Boca Raton, FL 33487

Phone: 561 634 7430

Last updated: 2024-12-31

Enveric Biosciences, Inc.

Enveric Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cannabinoid Medicines

Enveric Biosciences, Inc. is a pharmaceutical company focused on developing cannabinoid medicines for cancer care, including treatments for osteoarthritis, cancer-related distress, mental health, and topical skin applications.

Tags: biotechnology, cancer care, cannabinoid medicines, mental health, pharmaceuticals

Symbol: ENVB

Recent Price: $0.33

Industry: Biotechnology

CEO: Dr. Joseph Edward Tucker Ph.D.

Sector: Healthcare

Employees: 7

Address: 4851 Tamiami Trail North, Naples, FL 34103

Phone: 239 302 1707

Last updated: 2024-12-31

Moleculin Biotech, Inc.

Moleculin Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Annamycin

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company developing drug candidates for highly resistant tumors and viruses. Its lead product, Annamycin, is in Phase 1/2 studies, and it also works on other candidates targeting brain tumors, pancreatic cancer, and COVID-19.

Tags: Biotech, Cancer treatment, Clinical-stage, Drug development, Pharmaceutical, Phase 1/2 studies

Symbol: MBRX

Recent Price: $1.79

Industry: Biotechnology

CEO: Mr. Walter V. Klemp

Sector: Healthcare

Employees: 18

Address: 5300 Memorial Drive, Houston, TX 77007

Phone: 713 300 5160

Last updated: 2024-12-31

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

ANA001

A clinical-stage biotechnology company developing therapies for neurodegenerative, infectious, and cardiometabolic diseases.

Tags: biotechnology, cardiometabolic diseases, clinical trials, infectious diseases, neurodegenerative diseases

Symbol: NRBO

Recent Price: $2.36

Industry: Biotechnology

CEO: Mr. Hyung-Heon Kim

Sector: Healthcare

Employees: 8

Address: 200 Berkeley Street, Boston, MA 02116

Phone: 857 702 9600

Last updated: 2024-12-31

Unity Biotechnology, Inc.

Unity Biotechnology, Inc. logo
Market Cap: Lowest
Employees: Lowest

UBX1325

Unity Biotechnology, Inc. engages in the research and development of therapeutics aimed at slowing, halting, or reversing diseases of aging with a focus on eye-related conditions.

Tags: aging, biotechnology, drug development, ophthalmology, therapeutics

Symbol: UBX

Recent Price: $0.96

Industry: Biotechnology

CEO: Dr. Anirvan Ghosh Ph.D.

Sector: Healthcare

Employees: 19

Address: 285 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 416 1192

Last updated: 2024-12-31

Annovis Bio, Inc.

Annovis Bio, Inc. logo
Market Cap: Low
Employees: Lowest

Buntanetap

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound, Buntanetap, is in clinical trials for various neurodegenerative disorders.

Tags: Alzheimer's disease, Parkinson's disease, clinical trials, drug development, neurodegeneration

Symbol: ANVS

Recent Price: $5.08

Industry: Biotechnology

CEO: Dr. Maria L. Maccecchini Ph.D.

Sector: Healthcare

Employees: 6

Address: 1055 Westlakes Drive, Berwyn, PA 19312

Phone: 610 727 3913

Last updated: 2024-12-31

AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

epetraborole

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases, including epetraborole for non-tuberculous mycobacterial lung disease.

Tags: biopharmaceutical, boron chemistry, epetraborole, infectious diseases, non-tuberculous mycobacterial lung disease

Symbol: ANTX

Recent Price: $1.41

Industry: Biotechnology

CEO: Mr. Eric E. Easom

Sector: Healthcare

Employees: 41

Address: 1800 El Camino Real, Menlo Park, CA 94027

Phone: 650-331-9090

Last updated: 2024-12-31

Abeona Therapeutics Inc.

Abeona Therapeutics Inc. logo
Market Cap: Low
Employees: Low

EB-101

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.

Tags: EB-101, biopharmaceutical, cell therapy, clinical trials, gene therapy, rare genetic diseases

Symbol: ABEO

Recent Price: $5.61

Industry: Biotechnology

CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.

Sector: Healthcare

Employees: 84

Address: 1330 Avenue of the Americas, New York, NY 10019

Phone: 646 813 4701

Last updated: 2024-12-31

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation logo
Market Cap: Medium
Employees: Low

AB-729, AB-836, AB-161, AB-101

Arbutus Biopharma Corporation is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses. The company's HBV product pipeline includes RNA interference products and oral capsid inhibitors, and it is involved in strategic alliances for research and development.

Tags: HBV, Hepatitis B, RNA interference, SARS-CoV-2, biopharmaceutical, capsid inhibitor, coronaviruses, therapeutics

Symbol: ABUS

Recent Price: $3.20

Industry: Biotechnology

CEO: Mr. Michael J. McElhaugh

Sector: Healthcare

Employees: 73

Address: 701 Veterans Circle, Warminster, PA 18974

Phone: 267 469 0914

Leadership

  • Michael J. McElhaugh, Interim President and Chief Executive Officer and Director
  • Michael J. Sofia PhD, Chief Scientific Officer
  • Karen Sims, MD, PhD, Chief Medical Officer
  • David C. Hastings, Chief Financial Officer
  • Christopher Naftzger, General Counsel and Chief Compliance Officer
  • Lisa Caperelli, Vice President, Investor Relations
  • Shannon Briscoe, SPHR, SHRM-SCP, Vice President, Human Resources
  • Frank Torti, MD, Chairman
  • Daniel Burgess, Independent Director
  • Richard C. Henriques, Independent Director
  • Keith Manchester, MD, Independent Director
  • James Meyers, Independent Director
  • Melissa V. Rewolinski, PhD, Independent Director

Last updated: 2024-12-31